Shangli Zhang

Title: The Innovative Contributions of Shangli Zhang

Introduction

Shangli Zhang is a prominent inventor based in Jinan, China. He has made significant contributions to the field of biomedical research, particularly in the area of embryonic stem cell differentiation. His work has the potential to advance the development of new therapeutic strategies for vascular diseases.

Latest Patents

Shangli Zhang holds a patent for the application of 2,3-dihydro-3-hydroxymethyl-6-amino-[1,4]-benzoxazine in the preparation of drugs that induce embryonic stem cells to differentiate into vascular endothelial cells. The patent details that the concentration of this compound in the drug preparation is effectively set at 1:20 µM. This invention lays the foundation for preparing and developing drugs that can induce embryonic stem cells to differentiate into vascular endothelial cells. It serves as an effective research tool for studying embryonic stem cell differentiation and the molecular mechanisms of blood vessel formation.

Career Highlights

Shangli Zhang is affiliated with Shandong University, where he conducts his research and development activities. His work is recognized for its innovative approach to addressing complex biological challenges.

Collaborations

Shangli Zhang has collaborated with notable colleagues, including Baoxiang Zhao and Jing Zhao, to further enhance the impact of his research in the field of stem cell biology.

Conclusion

Shangli Zhang's contributions to the field of biomedical research, particularly through his patent on embryonic stem cell differentiation, highlight his role as an influential inventor. His work not only advances scientific understanding but also opens new avenues for therapeutic development.